Humana Inc. $HUM Shares Acquired by State of Wyoming

State of Wyoming boosted its position in shares of Humana Inc. (NYSE:HUM) by 93.0% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 9,372 shares of the insurance provider’s stock after buying an additional 4,515 shares during the period. Humana accounts for approximately 0.3% of State of Wyoming’s portfolio, making the stock its 27th biggest holding. State of Wyoming’s holdings in Humana were worth $2,400,000 at the end of the most recent quarter.

Other institutional investors also recently added to or reduced their stakes in the company. Illinois Municipal Retirement Fund increased its position in Humana by 9.6% during the third quarter. Illinois Municipal Retirement Fund now owns 49,658 shares of the insurance provider’s stock worth $12,920,000 after buying an additional 4,351 shares during the period. Long Focus Capital Management LLC acquired a new position in Humana during the third quarter worth approximately $34,212,000. AMG National Trust Bank increased its position in Humana by 106.5% during the third quarter. AMG National Trust Bank now owns 16,953 shares of the insurance provider’s stock worth $4,411,000 after buying an additional 8,744 shares during the period. Aberdeen Group plc increased its position in Humana by 18.1% during the fourth quarter. Aberdeen Group plc now owns 283,778 shares of the insurance provider’s stock worth $72,684,000 after buying an additional 43,442 shares during the period. Finally, Alberta Investment Management Corp acquired a new position in Humana during the third quarter worth approximately $4,735,000. Institutional investors and hedge funds own 92.38% of the company’s stock.

Humana Trading Up 2.2%

NYSE:HUM opened at $328.09 on Thursday. The firm has a market cap of $39.39 billion, a P/E ratio of 35.09, a PEG ratio of 2.33 and a beta of 0.76. The company has a current ratio of 1.77, a quick ratio of 1.77 and a debt-to-equity ratio of 0.66. The stock’s 50 day simple moving average is $241.36 and its 200-day simple moving average is $230.78. Humana Inc. has a 12-month low of $163.11 and a 12-month high of $333.31.

Humana (NYSE:HUM) last released its earnings results on Wednesday, April 29th. The insurance provider reported $10.31 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $9.97 by $0.34. The business had revenue of $39.65 billion for the quarter, compared to analyst estimates of $39.37 billion. Humana had a return on equity of 10.45% and a net margin of 0.82%.The company’s revenue for the quarter was up 23.5% compared to the same quarter last year. During the same quarter in the previous year, the company posted $11.58 earnings per share. Humana has set its FY 2026 guidance at 9.000- EPS. Equities analysts anticipate that Humana Inc. will post 9 EPS for the current year.

Humana Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Friday, July 31st. Investors of record on Friday, June 26th will be paid a $0.885 dividend. The ex-dividend date is Friday, June 26th. This represents a $3.54 dividend on an annualized basis and a dividend yield of 1.1%. Humana’s payout ratio is 37.86%.

Wall Street Analyst Weigh In

Several research analysts have commented on the company. William Blair assumed coverage on Humana in a research report on Wednesday, May 20th. They set an “outperform” rating on the stock. Weiss Ratings reaffirmed a “sell (d+)” rating on shares of Humana in a research report on Tuesday, April 21st. Wells Fargo & Company lowered Humana from a “cautious” rating to a “reduce” rating in a research report on Wednesday, May 20th. Wolfe Research lowered Humana from a “strong-buy” rating to a “peer perform” rating in a report on Wednesday, May 20th. Finally, TD Cowen boosted their target price on Humana from $173.00 to $211.00 and gave the company a “hold” rating in a report on Friday, May 1st. Nine analysts have rated the stock with a Buy rating, fifteen have issued a Hold rating and four have assigned a Sell rating to the company. According to data from MarketBeat, Humana currently has an average rating of “Hold” and a consensus target price of $276.17.

About Humana

Humana Inc (NYSE: HUM) is a health insurance company headquartered in Louisville, Kentucky, that primarily serves individuals and groups across the United States. The company is best known for its Medicare business, offering Medicare Advantage plans and prescription drug (Part D) coverage, alongside a range of commercial and employer-sponsored group health plans. Humana’s products are designed to cover medical, behavioral health and pharmacy needs for members, with particular emphasis on seniors and Medicare-eligible populations.

In addition to traditional insurance products, Humana provides care-management and wellness services intended to support chronic-condition management, preventive care and care coordination.